Pluri Inc. Professional Fees
Pluri Inc. (PLUR) reported Professional Fees of $1.80 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-09-10
- Pluri Inc. professional fees for the quarter ending 2026-06-30 was $389.00K, a 43.38% decline year-over-year.
- Pluri Inc. professional fees for the quarter ending 2026-03-31 was $332.00K, a 44.57% decline year-over-year.
- Pluri Inc. professional fees for the quarter ending 2025-12-31 was $512.00K, a 14.95% decline year-over-year.
- Pluri Inc. professional fees for the quarter ending 2025-09-30 was $567.00K, a 14.86% decline year-over-year.
- Pluri Inc. professional fees for fiscal 2026 was $1.80M, a 29.52% decline from fiscal 2025.
- Pluri Inc. professional fees for fiscal 2025 was $2.55M, a 5.79% decline from fiscal 2024.
- Pluri Inc. professional fees for fiscal 2024 was $2.71M.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month |
|---|---|---|---|---|
| 2026-06-30 | $389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $721.00K derived: sum of 2 quarters · filed 2026-09-10 | $1.23M derived: sum of 3 quarters · filed 2026-09-10 | $1.80M 10-K · filed 2026-09-10 |
| 2026-03-31 | $332.00K 10-Q · filed 2026-05-14 | $844.00K derived: sum of 2 quarters · filed 2026-05-14 | $1.41M 10-Q · filed 2026-05-14 | $2.10M derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-12-31 | $512.00K 10-Q · filed 2026-02-12 | $1.08M 10-Q · filed 2026-02-12 | $1.77M derived: sum of 3 quarters · filed 2026-09-10 | $2.37M derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-09-30 | $567.00K 10-Q · filed 2025-11-12 | $1.25M derived: sum of 2 quarters · filed 2026-09-10 | $1.85M derived: sum of 3 quarters · filed 2026-09-10 | $2.46M derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-06-30 | $687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $1.29M derived: sum of 2 quarters · filed 2026-09-10 | $1.89M derived: sum of 3 quarters · filed 2026-09-10 | $2.55M 10-K · filed 2026-09-10 |
| 2025-03-31 | $599.00K 10-Q · filed 2026-05-14 | $1.20M derived: sum of 2 quarters · filed 2026-05-14 | $1.87M 10-Q · filed 2026-05-14 | |
| 2024-12-31 | $602.00K 10-Q · filed 2026-02-12 | $1.27M 10-Q · filed 2026-02-12 | ||
| 2024-09-30 | $666.00K 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | $2.71M 10-K · filed 2025-09-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |